% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://docs.db.ripe.net/terms-conditions.html

% Information related to 'AS43063'

% Abuse contact for 'AS43063' is '[email protected]'

aut-num: AS43063
as-name: SPH-AS01
org: ORG-SJ6-RIPE
import: from AS20657 action pref=100; accept ANY
import: from AS8672 action pref=100; accept ANY
export: to AS20657 announce AS43063
export: to AS8672 announce AS43063
default: to AS20657 action pref=100; networks ANY
default: to AS8672 action pref=100; networks ANY
admin-c: AS43709-RIPE
tech-c: AS43709-RIPE
status: ASSIGNED
notify: [email protected]
mnt-by: MNT-ATLANTISBG
mnt-by: RIPE-NCC-END-MNT
created: 2007-06-01T06:55:16Z
last-modified: 2020-02-12T13:16:46Z
source: RIPE
sponsoring-org: ORG-ABL4-RIPE

organisation: ORG-SJ6-RIPE
org-name: SOPHARMA JSCo
country: BG
remarks: SOPHARMA is one of the leading pharmaceuticals company in Bulgaria
org-type: OTHER
address: 16 ILIENSKO SHOSE Str.
address: 1220 SOFIA
address: BULGARIA
phone: +359 2 8134200
admin-c: YB425-RIPE
tech-c: YB425-RIPE
e-mail: [email protected]
abuse-c: AC32772-RIPE
mnt-ref: MNT-ATLANTISBG
mnt-by: MNT-ATLANTISBG
created: 2007-05-28T14:09:05Z
last-modified: 2022-12-01T17:25:56Z
source: RIPE

person: Administrator Sopharma
address: 16 ILIENSKO SHOSE Str.
address: 1220 SOFIA
address: BULGARIA
e-mail: [email protected]
phone: +359 2 8134200
nic-hdl: AS43709-RIPE
mnt-by: ATLANTIS-GROUP-MNT
mnt-by: MNT-ATLANTISBG
created: 2020-02-12T13:01:46Z
last-modified: 2020-02-12T13:09:31Z
source: RIPE

% This query was served by the RIPE Database Query Service version 1.114 (SHETLAND)